Lv734
4970 积分 2024-02-29 加入
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
8小时前
已完结
Disulfidptosis in cancer: from redox stress to therapeutic strategy
12天前
已完结
Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy
23天前
已完结
Guidelines for T cell nomenclature
1个月前
已完结
In Situ Chimeric Antigen Receptor Macrophage Therapy via Co-Delivery of mRNA and Immunostimulant
1个月前
已完结
IDR-induced CAR condensation improves the cytotoxicity of CAR-Ts against low-antigen cancers
1个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
1个月前
已完结
Small-molecule control of CAR T cells
2个月前
已完结
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
2个月前
已完结
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma
2个月前
已完结
皖公网安备34019202002308
